The FDA granted orphan designation to Sanofi ( SNY) US Services’ rilzabrutinib as a treatment of autoimmune hemolytic anemia, according to a post to the agency’s website. Published first on TheFly – ...

In ulcerative colitis, duvakitug led to clinical remission in up to 48% of patients, with placebo-adjusted rates of 27% at the highest dose. In Crohn's disease, duvakitug achieved endoscopic ...

Boulder-based Enveda Biosciences, which uses machine learning to discover naturally occurring drug compounds, recently added ...

This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...

OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. Emma Roth is a news writer ...

German director Mehmet Akif Büyükatalay’s Hysteria has won the Europa Cinemas Label as Best European film in the Panorama section of the Berlin Film Festival. The film, which has received rave ...

The 10 films chosen for International Competition will compete for the Golden Alexander and the Silver Alexander – the festival’s top prizes. The winner of the Golden Alexander will receive a ...

From Golden Bear winner "Dreams (Sex Love)" to another movie called "Dreams," here are the best films we saw at the 2025 Berlinale. The 75th Berlin International Film Festival has wrapped its ...

It's take two for the Fyre Festival. "FYRE 2 is real. My dream is finally becoming a reality," Billy McFarland, the founder of the controversial festival, told TODAY in an interview that aired Feb ...

Tickets went on sale today for Fyre Festival Part 2 after the first ended up being a nightmare for participants. A court ruled the event’s founder, Billy McFarland, owes $26 million in restitution.

Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines, taking a 21-valent shot licensed from SK Biosciences into phase 3 testing.